دورية أكاديمية
CDK4/6 Inhibitors in Melanoma: A Comprehensive Review
| العنوان: | CDK4/6 Inhibitors in Melanoma: A Comprehensive Review |
|---|---|
| المؤلفون: | Garutti M., Targato G., Buriolla S., Palmero L., Minisini A. M., Puglisi F. |
| المساهمون: | Garutti, M., Targato, G., Buriolla, S., Palmero, L., Minisini, A. M., Puglisi, F. |
| سنة النشر: | 2021 |
| المجموعة: | Università degli Studi di Udine: CINECA IRIS |
| مصطلحات موضوعية: | Abemaciclib, CDK4, CDK4/6, CDK6, melanoma, Palbociclib, Ribociclib |
| الوصف: | Historically, metastatic melanoma was considered a highly lethal disease. However, recent advances in drug development have allowed a significative improvement in prognosis. In particular, BRAF/MEK inhibitors and anti-PD1 antibodies have completely revolutionized the management of this disease. Nonetheless, not all patients derive a benefit or a durable benefit from these therapies. To overtake this challenges, new clinically active compounds are being tested in the context of clinical trials. CDK4/6 inhibitors are drugs already available in clinical practice and preliminary evidence showed a promising activity also in melanoma. Herein we review the available literature to depict a comprehensive landscape about CDK4/6 inhibitors in melanoma. We present the molecular and genetic background that might justify the usage of these drugs, the preclinical evidence, the clinical available data, and the most promising ongoing clinical trials. |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| العلاقة: | info:eu-repo/semantics/altIdentifier/wos/WOS:000667856400001; volume:10; issue:6; firstpage:1334; journal:CELLS; http://hdl.handle.net/11390/1208046Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85107429643 |
| DOI: | 10.3390/cells10061334 |
| الإتاحة: | https://doi.org/10.3390/cells10061334Test http://hdl.handle.net/11390/1208046Test |
| حقوق: | info:eu-repo/semantics/openAccess |
| رقم الانضمام: | edsbas.B60B38FD |
| قاعدة البيانات: | BASE |
| DOI: | 10.3390/cells10061334 |
|---|